. 2022 Sep 3;11(17):5213. doi: 10.3390/jcm11175213

Table 1.

Incidence of anxiety and depressive psychiatric conditions in patients with COVID-19.

Population (Country)	Assessment	Psychiatric Conditions	Incidence	Ref.
126 (China)	Self-report questionnaire	Anxiety	22.2%	[11]
		PTSD	31%
		Depression	38.1%
402 (one month after hospital treatment) (Italy)	Self-report questionnaire	PTSD	28%	[12]
		Depression	31%
		Anxiety	42%
		Obsessive Compulsive Symptoms	20%
		Insomnia	40%
Prospective study in 44 hospitalized patients (USA)	HAD-A HAS-D	Depressive symptoms	29% (20% after 2 weeks)	[14]
		Anxiety	36% (9% after 2 weeks)
		Acute stress disorder syndrome	25% mild-moderate (after two weeks)
44,779 (the TriNetX Analytics Network)	Clinical diagnosis at 14–90 days (all first diagnoses)	Psychotic disorder	0.1%	[9]
		Any mood disorder	2%
		Depressive episode	1.7%
		Insomnia	1.9%
		Dementia	1.6%
236,379 (the TriNetX Analytics Network)	Clinical diagnosis at 6 months (all first diagnosis):	First dementia	0.67%	[8]
		Mood disorder	4.22%
		Anxiety	7.11%
		Psychotic features	0.42%
		Insomnia	2.56%
100 (UK)	Clinical evaluation	Any PTSD symptoms	41%	[15]
100 (UK)	Clinical evaluation	Thoughts of self-harm	2%	[15]
714 clinically stable patients (China)	Online PTSD questionnaire (PCL-C)	Significant post-traumatic stress symptoms	96.2%	[10]
57 (China)	Chinese version 9-item Patient Health Questionnaire (PHQ-9) and 7-item Generalized Anxiety Disorder (GAD-7) scale	Depression	29.2%	[13]
57 (China)		Anxiety	20.8%	[13]
153 (UK)	Clinical diagnosis	Affective disorder	2.6%	[16]
40,469 (the TriNetX Analytics Network)	Clinical diagnosis	Anxiety	4.6%	[6]
		Mood disorders	3.8%
		Suicidal ideation	0.2%
2150 hospital admitted patients (Spain)	Clinical diagnosis	Mood disorder	1.4%	[17]
2150 hospital admitted patients (Spain)	Clinical diagnosis	Anxiety-stress-adjustment disorder	11.9%	[17]